MYO
insider transactionsMYOMO, INC. — buys & sells by directors, officers and 10% owners A shareholder owning more than 10% of the company. Must report trades, but usually a weaker signal than an officer or director. (SEC Form 4).
Net shares · 30d
-32.0K
0 buy · 32.0K sell
Net value · 30d
-$32.2K
$0 in · $32.2K out
Sentiment · 30d
Net selling
0% buying · 100% selling
Open-market trades · 30d
2
0 buy · 32.0K sell
Net buy / sell volume
Not enough data to chart yet.
Tap or hover the chart for daily net volume. Green = net buying, red = net selling.
All transactions
-
Sell·S
Chief Medical Officer
$11.7K
11.5K sh · $1.02
Own -10%
-
Sell·S
Chief Medical Officer
$20.5K
20.5K sh · $1.00
Own -15%
| Date▾ | Insider | Type | Shares | Value |
|---|---|---|---|---|
| May 28, 2026 | Kovelman Harry | Sell S | 11.5K | $11.7K |
| May 27, 2026 | Kovelman Harry | Sell S | 20.5K | $20.5K |
About MYO insider trading
This page tracks insider transactions for MYOMO, INC. (MYO) reported to the U.S. Securities and Exchange Commission on Form 4. Corporate insiders — directors, executive officers and beneficial owners of more than 10% of the stock — must disclose their trades within two business days. Open-market purchases (code P) and sales (code S) made at the insider's discretion are the most-watched opportunistic signals, while awards (A), option exercises (M) and tax-withholding (F) reflect compensation rather than conviction. Trades marked 10b5-1 were made under a pre-arranged plan and are considered routine. A cluster buy — several insiders buying within a short window — is historically a stronger bullish indicator than any single trade.